Company coverage
Research snapshot 2026-08-31
Research activity
NNE 16 trade records · 1 option records · 2024-11-29 → 2026-01-28Moat
NarrowPre-commercialization company with patented microreactor designs (KRONOS MMR, ZEUS, LOKI MMR) but no economic moat currently. Faces competition from established nuclear companies (GE, Westinghouse, Rolls-Royce) and funded startups (X-energy, Commonw…
Physical assets
MinimalNo productive physical assets. Holds IP, lab facilities, and is pursuing construction permits. Microreactors would represent productive assets upon commercialization, but today they remain theoretical.
Software / hardware
Software15%
Hardware85%
Growth. KRONOS/ZEUS/LOKI microreactor designs target DOE approval and NRC licensing by 2027, positioning NNE for remote power, defense, and data center deployments. Primary assets. KRONOS, ZEUS, LOKI microreactor designs and patents, NRC licensing a…
- manual · sw-hw
Growth. KRONOS/ZEUS/LOKI microreactor designs target DOE approval and NRC licensing by 2027, positioning NNE for remote power, defense, and data center deployments. Primary assets. KRONOS, ZEUS, LOKI microreactor designs and pate…
- manual · physical-assets
No productive physical assets. Holds IP, lab facilities, and is pursuing construction permits. Microreactors would represent productive assets upon commercialization, but today they remain theoretical.
- manual · moat
Pre-commercialization company with patented microreactor designs (KRONOS MMR, ZEUS, LOKI MMR) but no economic moat currently. Faces competition from established nuclear companies (GE, Westinghouse, Rolls-Royce) and funded startup…
| Date | Action | Type | Relative size |
|---|---|---|---|
| 2026-01-28 | SELL | Equity | +51% |
| 2026-01-09 | BUY | Equity | +2% |
| 2026-01-08 | BUY | Equity | +5% |
| 2026-01-07 | BUY | Equity | +1% |
| 2025-12-22 | BUY | Equity | +1% |
| 2025-12-11 | BUY | Equity | +0% |
| 2025-11-14 | BUY | Equity | +1% |
| 2025-11-06 | BUY | Equity | +1% |
| 2025-11-04 | BUY | Equity | +1% |
| 2025-11-03 | BUY | Equity | +1% |
| 2025-10-24 | BUY | Equity | +1% |
| 2025-10-08 | BUY | Equity | +13% |
| 2025-08-26 | BUY | Equity | +1% |
| 2025-08-22 | BUY | Equity | +3% |
| 2025-08-22 | BUY | Equity | +21% |
| 2024-11-29 | BUY | CALL option | +100% |
Notes
Full portfolio moat / asset analysis
Pre-commercialization company with patented microreactor designs (KRONOS MMR, ZEUS, LOKI MMR) but no economic moat currently. Faces competition from established nuclear companies (GE, Westinghouse, Rolls-Royce) and funded startups (X-energy, Commonwealth Fusion). Requires DOE stamp of approval (expected early 2026) and NRC licensing (2026-2027). No sales or…
Full portfolio moat / asset analysis
No productive physical assets. Holds IP, lab facilities, and is pursuing construction permits. Microreactors would represent productive assets upon commercialization, but today they remain theoretical.
Open the working company page.
Authenticated sessions unlock the live watchlist controls, expanded market-data views, add-note workflow, and full internal timeline.